Abstract:Abstract Background Previous studies indicated that obesity would accelerate frailty progression. However, obesity is heterogeneous by different metabolic status. The associations of metabolic heterogeneity of obesity with frailty progression remain unclear. Methods A total of 6730 participants from the China Health and Retirement Longitudinal Study (CHARLS) and 4713 from the English Longitudinal Study of Ageing (ELSA) were included at baseline. Metabolic heterogeneity of obesity was evaluated based on four obesity and metabolic phenotypes as metabolically healthy normal weight (MHNW), metabolically unhealthy normal weight (MUNW), metabolically healthy overweight/obesity (MHOO), and metabolically unhealthy overweight/obesity (MUOO). Frailty status was assessed by the frailty index (FI) ranging from 0 to 100 and frailty was defined as FI ≥ 25. Linear mixed‐effect models were used to analyse the associations of metabolic heterogeneity of obesity with frailty progression. Results In the CHARLS, MUOO and MUNW presented the accelerated FI progression with additional annual increases of 0.284 (95% CI: 0.155 to 0.413, P < 0.001) and 0.169 (95% CI: 0.035 to 0.303, P = 0.013) as compared with MHNW. MHOO presented no accelerated FI progression (β: ‐0.011, 95% CI: −0.196 to 0.173, P = 0.904) as compared with MHNW. In the ELSA, the accelerated FI progression was marginally significant for MUOO (β: 0.103, 95% CI: −0.005 to 0.210, P = 0.061) and MUNW (β: 0.157, 95% CI: −0.011 to 0.324, P = 0.066), but not for MHOO (β: ‐0.047, 95% CI: −0.157 to 0.062, P = 0.396) in comparison with MHNW. The associations of MUOO and MUNW with the accelerated FI progression were stronger after excluding the baseline frail participants in both cohorts. The metabolic status changed over time. When compared with stable MHNW, participants who changed from MHNW to MUNW presented the accelerated FI progression with additional annual increases of 0.356 (95% CI: 0.113 to 0.599, P = 0.004) and 0.255 (95% CI: 0.033 to 0.477, P = 0.024) in the CHARLS and ELSA, respectively. The accelerated FI progression was also found in MHOO participants who transitioned to MUOO (CHARLS, β: 0.358, 95% CI: 0.053 to 0.663, P = 0.022; ELSA, β: 0.210, 95% CI: 0.049 to 0.370, P = 0.011). Conclusions Metabolically unhealthy overweight/obesity and normal weight, but not metabolically healthy overweight/obesity, accelerated frailty progression as compared with metabolically healthy normal weight. Regardless of obesity status, transitions from healthy metabolic status to unhealthy metabolic status accelerated frailty progression as compared with stable metabolically healthy normal weight. Our findings highlight the important role of metabolic status in frailty progression and recommend the stratified management of obesity based on metabolic status.

Association of metabolic syndrome severity with frailty progression among Chinese middle and old-aged adults: a longitudinal study

Longitudinal Changes of Cognition and Frailty with All-Cause and Cause-Specific Mortality in Chinese Older Adults: an 11-Year Cohort Study.

Prevalence and Associated Factors for Frailty among Elder Patients in China: a Multicentre Cross-Sectional Study

Dietary Patterns, Metabolomics and Frailty in a Large Cohort of 120 000 Participants.

Cognitive Frailty in Relation to Adverse Health Outcomes Independent of Multimorbidity in Chinese Older Adults

Relationship between skeletal muscle mass with metabolic syndrome in Chinese elders

The prevalence of frailty among patients with metabolic syndrome: a systematic review and meta-analysis

Gut Microbial Features and Circulating Metabolomic Signatures of Frailty in Older Adults

Prevalence of metabolic syndrome among middle-aged and elderly adults in China: current status and temporal trends

Incidence and risk factors of depression in patients with metabolic syndrome

Association Between Frailty, Metabolic Syndrome, and Mortality Across Young Population and Different Genders: Findings from National Health and Nutrition Examination Surveys (NHANES)

The prevalence and associated factors of metabolic syndrome in Chinese aging population

Associations of non-traditional cardiovascular risk factors and body mass index with metabolic syndrome in the Chinese elderly population

Associations of Metabolic Heterogeneity of Obesity with Frailty Progression: Results from Two Prospective Cohorts

Temporal trends in the prevalence of metabolic syndrome among middle-aged and elderly adults from 2011 to 2015 in China: the China health and retirement longitudinal study (CHARLS)

Association between metabolic syndrome severity score and cardiovascular disease: results from a longitudinal cohort study on Chinese adults

Association between physical frailty, circadian syndrome and cardiovascular disease among middle-aged and older adults: a longitudinal study

Changes in frailty and depressive symptoms among middle-aged and older Chinese people: a nationwide cohort study

The alterations in multiple neurophysiological procedures are associated with frailty phenotype in older adults

Prevalence and associated factors of metabolic syndrome in Chinese middle-aged and elderly population: a national cross-sectional study

Predictive role of depressive symptoms on frailty and its components in Chinese middle-aged and older adults: a longitudinal analysis